As production struggles to keep up, the pharma industry is now focusing on the upcoming patent expiry of key GLP-1 drugs like semaglutide, expected to start in early 2026 in countries like India, Brazil, China, and Canada (some reports even suggest 2025)
Take the poll on Health Risings Forums and tell us here
Digestive Health & IBS Naturopath Clinic in Edmonton IBS, Bloating, Candida, SIBO, Crohns, Colitis Treatment Gut issues
Key Facts Challenging the Brain-Centric Model : Clinical trials have long yielded contradictory data regarding GLP-1 drugs, with some showing antidepressant qualities and others hinting at mood liabilities
It contains nutrients that support healthier-looking skin and improve overall skin conditioning
Gut 1997